Evidence map›Paper›PMID 34567593›Full record

ArticleRoyal Society open science2021

Verification of the accuracy of the SIR model in forecasting based on the improved SIR model with a constant ratio of recovery to infection rate by comparing with monitored second wave data.

M Kröger, R Schlickeiser

Open access · goldAbstract read
In one paragraph

Article in Royal Society open science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

M KrögerDepartment of Materials, Polymer Physics, ETH Zurich, Zurich CH-8093, Switzerland.ORCID 0000-0003-1402-6714
R SchlickeiserInstitut für Theoretische Physik, Lehrstuhl IV: Weltraum- und Astrophysik, Ruhr-Universität Bochum, Bochum 44780, Germany.ORCID 0000-0003-3171-5079
Christian-Albrechts-Universität zu Kiel · DEETH Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The temporal evolution of second and subsequent waves of epidemics such as Covid-19 is investigated. Analytic expressions for the peak time and asymptotic behaviours, early doubling time, late half decay time, and a half-early peak law, characterizing the dynamical evolution of number of cases and fatalities, are derived, where the pandemic evolution exhibiting multiple waves is described by the semi-time SIR model. The asymmetry of the epidemic wave and its exponential tail are affected by the initial conditions, a feature that has no analogue in the all-time SIR model. Our analysis reveals that the immunity is very strongly increasing in several countries during the second Covid-19 wave. Wave-specific SIR parameters describing infection and recovery rates we find to behave in a similar fashion. Still, an apparently moderate change of their ratio can have significant consequences. As we show, the probability of an additional wave is however low in several countries due to the fraction of immune inhabitants at the end of the second wave, irrespective of the ongoing vaccination efforts. We compare with alternate approaches and data available at the time of submission. Most recent data serves to demonstrate the successful forecast and high accuracy of the SIR model in predicting the evolution of pandemic outbreaks as long as the assumption underlying our analysis, an unchanged situation of the distribution of variants of concern and the fatality fraction, do not change dramatically during a wave. With the rise of the

Indexed as

Coronavirusextrapolationpandemic spreadingparameter estimationstatistical analysis

Identifiers

PMID34567593
PMCPMC8456141
OpenAlexW3200983464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.